|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/08 | (2006.01) |
| A61K 49/14 | (2006.01) | ||
| A61K 48/00 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 3294345 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16793229.2 |
| Date of filing the European patent application | 2016-05-05 | |
| (97) | Date of publication of the European application | 2018-03-21 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-18 |
| (46) | Date of publication of the claims translation | 2024-02-12 |
| (86) | Number | PCT/US2016/031074 |
| Date | 2016-05-05 |
| (87) | Number | WO 2016/182862 |
| Date | 2016-11-17 |
| (30) | Number | Date | Country code |
| 201562158789 P | 2015-05-08 | US | |
| 201662300171 P | 2016-02-26 | US |
| (72) |
LESTER, Thomas, W. , US
MOSHASHAEE, Saeed , US
OKHAMAFE, Augustus, O. , US
O'NEILL, Charles, A. , US
|
| (73) |
BioMarin Pharmaceutical Inc. ,
105 Digital Drive, Novato, CA 94949,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | TPP1 vaisto formos ir CLN2 ligos gydymo būdai |
| TPP1 FORMULATIONS AND METHODS FOR TREATING CLN2 DISEASE |
| Payment date | Validity (years) | Amount | |
| 2025-04-23 | 10 | 231.00 EUR |
| 2026-05-05 |